U.S. Communications Stock News

If you are wondering whether Digital Realty Trust is attractively priced right now, you are not alone. The stock often catches the eye of investors who care about what they are really paying for each dollar of underlying fundamentals. At a last close of US$160.57, the stock has returned 5.0% over 7 days, 6.8% over 30 days, and 3.6% year to date. The 1 year return sits at an 8.1% decline, and the 3 and 5 year returns are 69.6% and 35.2% respectively. Recent attention on Digital Realty Trust...

Earlier this week, Chipotle Mexican Grill announced that Chief Human Resources Officer Ilene Eskenazi has become Chief Legal and Human Resources Officer, while Vice President of Brand Marketing Stephanie Perdue stepped in as Interim Chief Marketing Officer following the departures of Chief Legal Officer Roger Theodoredis and President, Chief Brand Officer Chris Brandt. These leadership changes consolidate Chipotle’s legal and people functions under one seasoned executive and temporarily...

Chevron stock triggered overview Chevron (CVX) has drawn fresh investor attention on the back of its recent share performance, with moves over the past week, month and past 3 months prompting closer scrutiny of its current valuation. See our latest analysis for Chevron. Chevron’s recent 30-day share price return of 13.23% and 7-day share price return of 4.34% suggest building short term momentum, while its 5-year total shareholder return of 123.35% points to stronger longer term compounding...

If you are wondering whether Virgin Galactic Holdings' current share price lines up with its underlying worth, this article walks through the key numbers so you can judge the valuation for yourself. The stock last closed at US$3.03, with returns of a 3.8% decline over 7 days, a 2.3% decline over 30 days, a 7.9% decline year to date, a 42.6% decline over 1 year, a 96.9% decline over 3 years, and a 99.5% decline over 5 years. Recent coverage has focused on Virgin Galactic's position as a...

Why Dycom Industries is on investors’ radar today Dycom Industries (DY) has been drawing fresh attention after recent trading, with the stock last closing at $365.65. For investors, the interest often centers on how that price lines up with current fundamentals. See our latest analysis for Dycom Industries. That recent 3.29% 1 day share price return, on top of a 25.01% 90 day share price return, sits against a 1 year total shareholder return of 92.52% and 5 year total shareholder return of...

Recent enthusiasm around Ocular Therapeutix (OCUL) has been tied to progress on its XPaxley treatment for wet age related macular degeneration, together with expectations for an accelerated FDA submission timeline. See our latest analysis for Ocular Therapeutix. Those XPaxley milestones have come during a choppy period for the share price, with a 1 day share price return of 1.9% at US$11.28, compared with a 30 day share price return decline of 21.6% and a 1 year total shareholder return of...

Mattel (MAT) is back in focus after fresh interest in its toy and family entertainment portfolio, prompting investors to reassess the stock using its recent share performance and fundamentals as reference points. See our latest analysis for Mattel. Recent interest in Mattel comes against a backdrop of a 90 day share price return of 18.14% and a 1 year total shareholder return of 21.24%, suggesting momentum has been building from both a price and dividends perspective. If you are weighing up...

If you are wondering whether Globalstar's share price still makes sense after a big run, or if expectations are getting ahead of reality, this article breaks down what the current price could imply about its underlying value. Globalstar closed at US$62.79, with returns of 5.1% over the last week, a 1.4% decline over the last month, a 1.9% decline year to date, and gains of 125.1% over 1 year, 217.1% over 3 years, and 237.6% over 5 years. These moves have put Globalstar on more investors'...

A Montana federal judge has allowed a PFAS related class-action lawsuit against DuPont de Nemours (DD) and other manufacturers to proceed, keeping potential RICO and multi state claims in play for now. See our latest analysis for DuPont de Nemours. The latest legal setback arrives after a sharp 45.47% decline in DuPont de Nemours' 90 day share price return, even as its 1 year total shareholder return of 38.25% and 3 year total shareholder return of 51.40% reflect a stronger longer term...

Unusual Machines (UMAC) is back in focus after announcing a new US$2.1 million purchase order for domestically assembled drone systems serving defense and government customers, with fulfillment planned across the first half of the year. See our latest analysis for Unusual Machines. The purchase order lands on top of a sharp recent move in the shares, with a 30 day share price return of 87.74% and a 1 year total shareholder return of 29.62%. This suggests momentum has been building into the...

Earlier this month, The Vita Coco Company appointed veteran retail executive Shelley Broader as a Class II director, adding more than 25 years of global leadership experience across mass and specialty retail, grocery, and consumer brands to its board. On the marketing front, Vita Coco is also extending its partnership with U.S. Men’s National Team star Weston McKennie as Global Brand Ambassador, aligning the brand with a high-profile athlete as soccer’s biggest international tournament comes...

Earlier in January 2026, Bruker’s Energy & Supercon Technologies (BEST) division announced two expanded multi-year superconductor supply agreements for MRI magnets, with a combined expected value of about US$500 million and durations including one contract extending up to seven years. By deepening long-term relationships with global radiology manufacturers and supporting helium-free MRI architectures, BEST is reinforcing Bruker’s role in enabling next-generation medical imaging and wider...

In January 2026, Xenon Pharmaceuticals presented at the 44th Annual J.P. Morgan Healthcare Conference, outlining clinical and regulatory plans for its lead epilepsy candidate azetukalner, including expected Phase 3 data in March 2026 and an NDA filing target in the second half of 2026. A distinctive aspect of the update was Xenon’s emphasis on azetukalner’s broader potential, with ongoing Phase 3 programs extending into neuropsychiatric indications such as major depressive disorder, where...

Semtech (SMTC) is back in focus after a strong Q3, with 12.8% year on year revenue growth and earnings ahead of analyst expectations, alongside sector tailwinds linked to AI driven semiconductor demand. See our latest analysis for Semtech. Sustained interest in AI related semiconductors has helped Semtech’s share price, which now trades at US$77.26 after a 4.15% 1 day share price return and a 13.99% 90 day share price return. Its 3 year total shareholder return of about 15x contrasts with a...

Whirlpool (WHR) has come back onto investors’ radars after its recent share price move, with the stock up around 12% over the past month and roughly 16% in the past 3 months. See our latest analysis for Whirlpool. That recent momentum, including a 12.1% 30 day share price return and 16.5% 90 day share price return, contrasts with Whirlpool’s 30.1% 1 year total shareholder return loss. As a result, short term optimism is building off a weaker longer term track record. If Whirlpool’s move has...

Salesforce (CRM) is back in focus after recent share price pressure, with the stock showing negative returns over the past week, month, past 3 months and year. That has some investors reassessing what they are paying for its growth profile. See our latest analysis for Salesforce. At a share price of $233.53, Salesforce has seen pressure build recently, with a 7 day share price return of 10.36% and a 1 year total shareholder return of 26.55% decline, even though the 3 year total shareholder...

Interactive Brokers announced in January 2026 that eligible IB LLC clients can now fund their brokerage accounts with stablecoins like USDC, enabling near-instant, 24/7 deposits that are automatically converted to US dollars with no deposit fee from the broker and a 0.30% conversion fee from zerohash. This move directly tackles long-standing cross-border funding frictions for international investors, potentially making Interactive Brokers more attractive to globally active and...

First Interstate BancSystem recently reported mixed quarterly results, with flat year-on-year revenue, an earnings-per-share beat, and a shortfall in net interest income versus analyst expectations. While management underscored its long-term plan around organic growth and tighter cost control, some analysts highlighted weakening revenue trends and projected net interest income declines as potential constraints on future profitability. We’ll now explore how these mixed results, particularly...

In recent days, Bank of New York Mellon Corporation reported record fourth-quarter 2025 net income of US$1,461 million and earnings per share ahead of expectations, alongside Board approval of a US$0.53 common dividend and multiple preferred dividends. The company paired these results with new medium-term financial targets and fresh fixed-income offerings totaling about US$1.55 billion, underscoring its push to fund technology, AI and digital asset initiatives while continuing substantial...

NeoGenomics, Inc. recently announced a planned Chief Financial Officer transition, with industry veteran Abhishek Jain set to assume the CFO role on March 2, 2026, following preliminary unaudited 2025 revenue of about US$190 million for the fourth quarter and US$727 million for the full year. This combination of leadership change and double‑digit revenue growth guidance raises questions about how NeoGenomics will balance financial discipline with its expansion in oncology diagnostics. Next,...

If you are wondering whether Independence Realty Trust is attractively priced or not, you are in the right place to get a clear view of what the current share price might be implying. The stock closed at US$17.08 recently, with returns of a 2.3% decline over 7 days, 0.6% over 30 days, a 3.0% decline year to date, a 6.8% decline over 1 year, 7.8% over 3 years and 48.0% over 5 years. Taken together, this gives you a mixed picture of short-term softness and longer-term gains. Recent coverage of...

Caledonia Mining (NYSEAM:CMCL) is drawing attention after upsizing its convertible senior notes offering to US$125 million to help fund the Bilboes gold project, and it has also reported 2025 Blanket Mine production in line with guidance. See our latest analysis for Caledonia Mining. The sharp 16.9% one day share price decline and softer 7 day move come after a period where the 30 day share price return is 11.8%, while the 1 year total shareholder return is very large at almost 3x. This...

Recent performance snapshot for Nutanix (NTNX) With no single headline event setting the tone, Nutanix (NTNX) has been drawing attention for its recent share performance, including a last close of $48.67 and mixed short and longer term total returns. See our latest analysis for Nutanix. Recent trading has been choppy, with a 1 day share price return of a 5.38% decline and a 7 day share price return of an 8.36% decline. The 1 year total shareholder return of a 26.87% decline contrasts with an...

Nuvation Bio (NUVB) is back in focus after signing an exclusive license and collaboration agreement with Eisai for taletrectinib, bringing immediate cash payments and potential milestones tied to global expansion beyond its existing markets. See our latest analysis for Nuvation Bio. Despite the Eisai agreement and recent conference visibility, Nuvation Bio’s share price return has seen a 27.34% fall over the past week and a 29.10% decline over the past month. At the same time, the 90 day...